Rivia
Rivia is a unified data and AI analytics platform designed for biotech and pharmaceutical companies to optimize clinical trials. It integrates fragmented trial data from multiple vendor sources into…
Rivia
Rivia is a unified data and AI analytics platform designed for biotech and pharmaceutical companies to optimize clinical trials. It integrates fragmented trial data from multiple vendor sources into…
TL;DR
What they do: Unified clinical-trial data & AI analytics platform (Rivia Core, Rivia Detect, Rivia Spark) for biotech and pharma
Headquarters: Zürich, Switzerland
Founding year: 2022
Stage / recent raise: Series A reported March 2026 (~€13M / ~$14.7M)
Notable investors: Earlybird, Speedinvest, Amino Collective, Nina Capital, Defiant
Company Overview
Problem Domain
Clinical trial data fragmentation, data quality and slow decision-making in drug development.
Founded
2022
Industry
Software Development
Tech Stack
Funding Track Record
€3,000,000
Reported seed round (~€3M) with participation from Speedinvest, Amino Collective and Nina Capital.
€13,000,000
Series A reported March 2026; reported amounts vary (~€13M / €14.7M reported in some coverage).
Investor Signal
“Participation from European VCs (Earlybird, Speedinvest, Amino Collective, Nina Capital, Defiant) indicates institutional VC backing and cross-border investor interest”
